EDGAR Filing Documents for 0001213900-14-008054

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-14-008054

Filing Date

2014-11-13

Accepted

2014-11-13 16:22:59

Documents

Period of Report

2014-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	f10q0914_calderapharma.htm	10-Q	754696
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	f10q0914ex31i_caldera.htm	EX-31.1	18902
3	CERTIFICATION OF CHIEF FINANCIAL OFFICER	f10q0914ex31ii_caldera.htm	EX-31.2	18843
4	CERTIFICATION PURSUANT TO	f10q0914ex32i_caldera.htm	EX-32.1	7049
5	CERTIFICATION PURSUANT TO	f10q0914ex32ii_caldera.htm	EX-32.2	6407
	Complete submission text file	0001213900-14-008054.txt		6341724

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE FILE	cpsc-20140930.xml	EX-101.INS	842766
7	XBRL SCHEMA FILE	cpsc-20140930.xsd	EX-101.SCH	59685
8	XBRL CALCULATION FILE	cpsc-20140930_cal.xml	EX-101.CAL	48444
9	XBRL DEFINITION FILE	cpsc-20140930_def.xml	EX-101.DEF	185103
10	XBRL LABEL FILE	cpsc-20140930_lab.xml	EX-101.LAB	529096
11	XBRL PRESENTATION FILE	cpsc-20140930_pre.xml	EX-101.PRE	356144

Mailing Address 278 DP ROAD SUITE D LOS ALAMOS NM 87544

Business Address 278 DP ROAD SUITE D LOS ALAMOS NM 87544 505-661-2420

Caldera Pharmaceuticals Inc (Filer) CIK: 0001518520 (see all company filings)